Enzyl 40mg Capsule

About Enzyl 40mg Capsule

Enzyl 40mg Capsule contains Enzalutamide, a targeted anticancer medication that belongs to the androgen receptor inhibitor class and is used in the treatment of advanced prostate cancer in adult men whose disease no longer responds adequately to surgical or hormonal therapies. It works by blocking the action of male hormones (androgens) that stimulate the growth and spread of prostate cancer cells, thereby helping to slow cancer progression and improve treatment outcomes. Patients should not take Enzyl 40mg Capsule if they are allergic to Enzalutamide or any of its ingredients. During treatment, doctors may regularly monitor prostate-specific antigen (PSA) levels, liver function tests, and complete blood counts (CBC) to assess treatment effectiveness and detect potential side effects early. Patients with a history of seizures should use this medication with caution, as Enzalutamide may increase the risk of seizure activity. Grapefruit and grapefruit juice should be avoided during therapy because they can increase the levels of the medication in the body and raise the risk of side effects. This medicine may cause harm to an unborn baby and may also affect fertility; therefore, patients should discuss fertility preservation and family planning options with their healthcare provider before starting treatment. Effective contraception is recommended for both men and women during treatment and for at least three months after the final dose. Regular medical monitoring and adherence to prescribed therapy are essential to ensure the safe and effective use of Enzyl 40mg Capsule in the management of advanced prostate cancer.